MindRank Announces First Patient Dosed in Phase III Trial of AI-Designed Oral GLP-1 Receptor Agonist MDR-001
Source: MindRank AI Ltd. | GlobeNewswire Inc. SHANGHAI, China, Feb. 25, 2026 (GLOBE NEWSWIRE) — MindRank, a clinical-stage...
MindRank Announces First Patient Dosed in Phase III Trial of AI-Designed Oral GLP-1 Receptor Agonist MDR-001
Source: MindRank AI Ltd. | GlobeNewswire Inc. SHANGHAI, China, Feb. 25, 2026 (GLOBE NEWSWIRE) — MindRank, a clinical-stage...
MindRank Announces First Patient Dosed in Phase III Trial of AI-Designed Oral GLP-1 Receptor Agonist MDR-001
Source: MindRank AI Ltd. | GlobeNewswire Inc. SHANGHAI, China, Feb. 25, 2026 (GLOBE NEWSWIRE) — MindRank, a clinical-stage...
MindRank Announces First Patient Dosed in Phase III Trial of AI-Designed Oral GLP-1 Receptor Agonist MDR-001
Source: MindRank AI Ltd. | GlobeNewswire Inc. SHANGHAI, China, Feb. 25, 2026 (GLOBE NEWSWIRE) — MindRank, a clinical-stage...
New ETH Zurich Study Proves Your AI Coding Agents are Failing Because Your AGENTS.md Files are too Detailed
Source: MarkTechPost In the high-stakes world of AI, ‘Context Engineering’ has emerged as the latest frontier for squeezing...